Lv5
1490 积分 2022-11-26 加入
The paradox of SGLT2 inhibitors in heart failure: Caution with drug target Mendelian randomization
2个月前
已完结
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
2个月前
已完结
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
2个月前
已完结
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
2个月前
已完结
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
2个月前
已完结
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
2个月前
已完结
Laparoscopic Dissection of the Pelvic Ureter: Rules of Engagement
5个月前
已完结
Preventive Health Examinations and Preventive Gynecological Examinations in the United States
6个月前
已完结
从1例反复发作口腔溃疡患者的接诊谈全科医生对性传播疾病患者的全人照顾
6个月前
已完结
皖公网安备34019202002308
